An article, “This Is What’s Missing in the Data-Centric Approach to Cancer,” by Barb Darrow, on Fortune.com discusses the start-up, Tempus. Eric Lefkofsky, a co-founder, believes doctors and research communities need more information collected from past, current, and future cancer patients, in order give the patient better treatment. Mr Lefkofsky has made the connection, through his own wife’s battle with cancer, that clinical information on how a treatment has worked, from one patient to another, is not being shared effectively with researchers, doctors, and other people who may need to know.
Tempus is a company that takes the electronic medical records (EMR) of a patient, creates a clean version, without their personal information, and gives it back to the source. The doctor/hospital is then able to use the information to find patterns and ideas on how their treatments have worked on a variety of different people. Lefkofsky believes that by having patient’s results’ readily available for research, will individualize the possibility for a positive treatment on future patients.
Eric Lefkofsky likes to start new companies and sell them for profit. He has been extremely successful. He is currently co-founder, CEO of Tempus, co-founder, Chairman of Groupon, and co-founder of Uptake Technologies, Mediaocean, Echo, Global Logistics, and Inner Workings. Lefkofsky earned his undergraduate degree from the University of Michigan and his Juris Doctorate degree from the University ofMichigan Law School.
Lefkofsky, and his wife Liz, started the Lefkofsky Family Foundation, to contribute in areas, such as, education, science, and causes around the globe that will make the lives of people in their communities better. Lefkofsky also works with Lurie Children’s Hospital of Chicago, The Museum of Science and Industry and World Business Chicago, and The Art Institute of Chicago. Lefkofsky works as an adjunct professor at the University of Chicago, and he has written a book, “Accelerated Disruption”.